search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
428


24-week period (Supplementary Fig. S1 online). The wards included medical and surgical wards, in addition to the intensive care unit (ICU). The study commenced in November 2017 and concluded in May 2018. A cross-sectional anonymous online survey was conducted at the end of the study period, in addition to a focus-group interview. The study was registered with the Australian and New Zealand Clinical Trial Registry (no. ACTRN12617001191381), and a study protocol has been published.3


Participants and eligibility


All hospitalized patients in eligible wards of the hospital who had an indwelling urinary catheter as part of their usual clinical care were included in the study. Patients <2 years old were excluded. The participants in the online survey and focus group were nursing staff; this group was chosen because they were directly involved in the intervention and urinary catheter care.


Ethics


Ethics approval was obtained from thehuman research ethics com- mittees of Avondale College of Higher Education (2017: 15) and Townville Hospital and Health Service (no. HREC17QTHS19). A waiver of individual patient consent was obtained for this study.


Randomization and blinding


Using computer-generated randomization, eligible wards in the hospital were randomly assigned to cross over to the intervention every 4 weeks over the trial duration. Randomization was per- formed by a person not involved in the study. The allocation was performed immediately prior to the commencement of the study. Wards were not blinded because it was not feasible to blind the staff to the intervention.


Intervention


The intervention was the use of the CATH TAG. The CATH TAG is an electronic device in the form of a sticker that attaches to the catheter bag with adhesive (Supplementary Fig. S2 online). It is lightweight and has a nonintrusive green light that flashes intermit- tently for a period of 24 hours upon activation. After 24 hours, the green flashing light changes to red, flashing with increased rapidity and visibility. The red flashing light is an indication that the nurse should reassess the need for a urinary catheter and should remove it if it is no longer required. There is no option for nurses to manipulate the flashing light or amend the flashing cycle. A variety of methods were used to raise awareness about the


how to use the CATH TAG, including wall posters, flyers, information leaflets, and engagement with the nursing managers at the ward level. These focused on the use of the CATH TAG and study, not catheterization practices or duration. Further details regarding the intervention, including fidelity, are detailed in supplementary material.


Outcomes


We considered two primary outcomes for the study: (1) urinary catheter duration and (2) the perceptions of nurses about the ease of use of the CATH TAG. In our initial protocol, the primary out- comes were the urinary catheter device utilization ratio and the per- ceptions of nurses. Prior to analysis, it became evident that the research team was not able to obtain patient-day data that aligned precisely with the date when a ward switched fromthe control to the


Brett G. Mitchell et al


Table 1. Characteristics of Study Participants with an Indwelling Urinary Catheter Variable


Control Phase, No. (%)


Participants Age


Median IQR


Sex


Female Male


Infectious diagnosis Yes


291 (48.9) 304 (51.1)


391 (65.7)


235 (41.1) 337 (58.9)


421 (73.6)


.05 .03


.05


intervention. Therefore, the team decided to amend the primary outcome to urinary catheter duration, which is consistent with the approach taken in other studies.2 The change was approved by the clinical trial registry prior to analysis being undertaken. Secondary outcomes included the number of cases of catheter-


associated asymptomatic bacteriuria per 100 catheter days, percep- tions of nurses about effectiveness of the CATH TAG, changes in ownership or interest by patients in catheter management, and barriers to the CATH TAG working successfully in various types of patients.


Perceptions of nurses


A phenomenological approach, seeking to understand the partic- ipants’ lived experience of a phenomenon, was the theoretical underpinning for the data collection and analysis methods used in association with the focus group. The purpose of the focus group was to gain an in-depth understanding of a sample of participants. Focus-group participants received a gift card to compensate them for their time because attendance occurred on their own time.


Statistical analysis


Catheter duration The analysis employed an intention-to-treat strategy and involved the inclusion of all patients in the randomized clusters in the analysis, regardless of any deviations from the study protocol. We used a Cox proportional hazards model to assess the rate of removal of cath- eters, with the duration of catheterization censored at the time of patient transfer and the intervention considered as a time-varying covariate. That is, the effect of the intervention was assumed to relate to the ward on which the patient was cared for. In this model, the hazard ratio (HR)represents the hazard of catheter removal, such that HR >1 represents earlier removal. In a subanalysis, we repeated the Cox proportional hazards regression, excluding patients in the inten- sive care unit (ICU). There is a strong rationale for subanalysis based on differing results between ICU and non-ICU settings for CAUTI interventions.4 In a sensitivity analysis,we repeated themodel, adjust- ing for sex, age and the presence of a primary infective diagnosis. We assessed the risk of bacteriuria using aconditional logistic regression, with intervention as the only independent variable, adjusted for clus- tering at the patient level.


Survey and focus group Mean responses to Likert questions were calculated. An indepen- dent t test was used to compare means. For reliability testing, we


595 66 54, 75


Intervention Phase, No. (%)


572 63 49, 73


P Value :::


<.01 <.01


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122